SO
ICPT

STRS Ohio’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

STRS Ohio’s Portfolio ICPT Stock Details ICPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-36,200
Closed -$504K – 2100
2022
Q3 		$504K Sell
36,200
-10,900
-23% -$176K ﹤0.01% 1331
2022
Q2 		$650K Buy
47,100
+19,400
+70% +$311K ﹤0.01% 1202
2022
Q1 		$450K Sell
27,700
-23,400
-46% -$367K ﹤0.01% 1484
2021
Q4 		$832K Hold
51,100
– – ﹤0.01% 1239
2021
Q3 		$758K Buy
51,100
+35,500
+228% +$568K ﹤0.01% 1307
2021
Q2 		$311K Buy
+15,600
New +$309K ﹤0.01% 1706
2020
Q3 		– Sell
-1,100
Closed -$52K – 2305
2020
Q2 		$52K Buy
1,100
+1,000
+1,000% +$77.3K ﹤0.01% 1910
2020
Q1 		$6K Sell
100
-1,900
-95% -$171K ﹤0.01% 1970
2019
Q4 		$247K Buy
+2,000
New +$179K ﹤0.01% 1634
2019
Q2 		– Sell
-800
Closed -$89K – 2231
2019
Q1 		$89K Sell
800
-500
-38% -$54.6K ﹤0.01% 1807
2018
Q4 		$131K Buy
1,300
+300
+30% +$31.1K ﹤0.01% 1714
2018
Q3 		$126K Buy
+1,000
New +$106K ﹤0.01% 1797
2015
Q1 		– Sell
-40,000
Closed -$6.24M – 1885
2014
Q4 		$6.24M Buy
+40,000
New +$7.39M 0.03% 468
2014
Q2 		– Sell
-800
Closed -$264K – 1776
2014
Q1 		$264K Buy
+800
New +$270K ﹤0.01% 1358
2013
Q4 		– Sell
-2,422
Closed -$167K – 1840
2013
Q3 		$167K Hold
2,422
– – ﹤0.01% 1544
2013
Q2 		$109K Buy
+2,422
New +$82.7K ﹤0.01% 1617

Other funds holding ICPT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

STRS Ohio's ICPT Position: Q4 2022 in Review

STRS Ohio sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q4 2022, closing a stake of 36,200 shares — an estimated $504K sold.

STRS Ohio first reported a position in ICPT in Q2 2013 and held it in 16 quarters. The position peaked at $6.24M in Q4 2014. 144 funds tracked by Wall St. Rank hold ICPT as of Q4 2022.

  • STRS Ohio reported no remaining Intercept Pharmaceuticals, Inc. position as of Q4 2022 after selling out during the quarter.
  • STRS Ohio sold 36,200 Intercept Pharmaceuticals, Inc. shares in Q4 2022, an estimated $504K.
  • STRS Ohio first reported a position in Intercept Pharmaceuticals, Inc. in Q2 2013 and held it in 16 quarters.
  • STRS Ohio's Intercept Pharmaceuticals, Inc. position peaked at $6.24M in Q4 2014.
  • 144 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q4 2022.

Based on STRS Ohio's 13F filing for Q4 2022, filed 26 Jan 2023.